<table border="1" id="id_3ae08a70-c3b1-4700-8402-8af67bf08df6" width="455.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_fc07febc-7b55-462b-9bc4-734b0b49744c">TABLE 1: SUMMARY OF EFFECTIVENESS DATA IN PLACEBO-CONTROLLED TRIALS</caption>
<col width="16.7%"></col>
<col width="7.5%"></col>
<col width="16.7%"></col>
<col width="15.8%"></col>
<col width="10.1%"></col>
<col width="18.9%"></col>
<col width="14.3%"></col>
<tbody>
<tr id="id_b21d532c-895b-4ff2-8b92-077c35c08a78">
<td align="left" rowspan="2" stylecode="Botrule Toprule Rrule Lrule" valign="middle">
<content stylecode="bold"> </content>
</td>
<td align="center" colspan="3" stylecode="Botrule Rrule" valign="middle">
<content stylecode="bold">SYMPTOM SCORE</content>
<footnote id="id-cfeac45b-e7a5-404b-95f4-18ddedf82e4d">AUA questionnaire (range 0 to 30) in <content stylecode="bold">STUDIES 1</content> and <content stylecode="bold">3</content>. Modified Boyarsky Questionnaire (range 7 to 39) in<content stylecode="bold"> STUDY 2</content>.</footnote>
</td>
<td align="center" colspan="3" stylecode="Botrule Rrule" valign="middle">
<content stylecode="bold">MAXIMUM FLOW RATE (mL/sec)</content>
<content stylecode="bold"> </content>
</td>
</tr>
<tr id="id_fbd1ff15-4b5a-44fc-81d3-1de66cb04b63">
<td align="center" stylecode="Lrule Botrule Rrule" valign="middle">
<content stylecode="bold">
<content stylecode="underline">N</content>
</content>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">
<content stylecode="bold">MEAN </content>
<content stylecode="underline">
<content stylecode="bold">BASELINE</content>
</content>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">
<content stylecode="bold">MEAN</content>
<content stylecode="bold">
<content stylecode="underline">CHANGE<footnote id="id-2a85cf3e-c53e-4630-8cbb-da4b41da184c">Change is to endpoint.</footnote>
</content>
</content>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">
<content stylecode="bold">
<content stylecode="underline">N</content>
</content>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">
<content stylecode="bold">MEAN <content stylecode="underline">BASELINE</content>
</content>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">
<content stylecode="bold">MEAN</content>
<content stylecode="bold">
<content stylecode="underline">CHANGE<footnote id="id-aeb2c8f4-aabe-4ec0-b90a-0716d43f9b0b">Change is fixed-dose efficacy phase, 22 to 26 hours post-dose for <content stylecode="bold">STUDIES 1</content> and <content stylecode="bold">3</content> and 2 to 6 hours post-dose for <content stylecode="bold">STUDY 2</content>.</footnote>
</content>
</content>
</td>
</tr>
<tr id="id_e7c52d6a-32c2-4929-b1c2-c807409e4e50">
<td align="left" colspan="7" stylecode="Lrule Botrule Rrule" valign="middle">
<content stylecode="bold">STUDY 1 (Titration to maximum dose of 8 mg)</content>
<footnote id="id-79427efb-dce1-496e-b7f1-5a8dbae819ab">36 patients received a dose of 8 mg doxazosin mesylate.</footnote>
</td>
</tr>
<tr id="id_249fd23f-6ea8-4a79-829b-8ad492b87a08">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">Placebo</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">47</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">15.6</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">-2.3</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">41</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">9.7</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">+0.7</td>
</tr>
<tr id="id_e61aca16-fc1c-4988-865a-7d27e4bf014a">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">Doxazosin mesylate</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">49</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">14.5</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">-4.9<footnote id="id-5063c552-a506-4573-ab49-071c18bbb4a6">p &lt; 0.01 compared to placebo mean change.</footnote>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">41</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">9.8</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">+2.9<footnoteref idref="id-5063c552-a506-4573-ab49-071c18bbb4a6"></footnoteref>
</td>
</tr>
<tr id="id_4e1c87cf-d947-4243-bc43-394fa6e9f998">
<td align="left" colspan="7" stylecode="Lrule Botrule Rrule" valign="middle">
<content stylecode="bold">STUDY 2 (Titration to fixed dose-14 weeks)</content>
<footnote id="id-686838c7-2b8f-45d0-91aa-5b26a894fc5f">Study in hypertensives with BPH.</footnote>
</td>
</tr>
<tr id="id_3f211dde-b345-42ad-b111-2164f655a6d5">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">Placebo</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">37</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">20.7</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">-2.5</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">30</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">10.6</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">+0.1</td>
</tr>
<tr id="id_35efd214-1174-4d13-a7ce-2bb6b5540760">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">Doxazosin mesylate 4 mg</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">38</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">21.2</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">-5.0<footnoteref idref="id-5063c552-a506-4573-ab49-071c18bbb4a6"></footnoteref>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">32</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">9.8</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">+2.3<footnote id="id-6b3d9dd2-9d9b-4181-a141-14ba88002bb7">p &lt; 0.05 compared to placebo mean change.</footnote>
</td>
</tr>
<tr id="id_a0d90b42-489e-4b99-99e0-dac236971011">
<td align="left" stylecode="Lrule Botrule Rrule" valign="middle">Doxazosin mesylate 8 mg</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">42</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">19.9</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">-4.2<footnoteref idref="id-6b3d9dd2-9d9b-4181-a141-14ba88002bb7"></footnoteref>
</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">36</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">10.5</td>
<td align="center" stylecode="Botrule Rrule" valign="middle">+3.3<footnoteref idref="id-5063c552-a506-4573-ab49-071c18bbb4a6"></footnoteref>
</td>
</tr>
<tr id="id_99ed9145-e93e-4f5b-bf3e-68f70e44f718">
<td align="left" colspan="7" stylecode="Lrule Botrule Rrule" valign="top">
<content stylecode="bold">STUDY 3 (Titration to fixed dose-12 weeks)</content>
</td>
</tr>
<tr id="id_c44e8310-2c11-41a4-9d7b-416fda7629c9">
<td align="left" stylecode="Lrule Botrule Rrule" valign="top">Placebo </td>
<td align="left" stylecode="Botrule Rrule" valign="top"> 47</td>
<td align="left" stylecode="Botrule Rrule" valign="top"> 14.9</td>
<td align="left" stylecode="Botrule Rrule" valign="top"> -4.7</td>
<td align="left" stylecode="Botrule Rrule" valign="top"> 44</td>
<td align="left" stylecode="Botrule Rrule" valign="top"> 9.9</td>
<td align="left" stylecode="Botrule Rrule" valign="top"> +2.1</td>
</tr>
<tr id="id_cb72abda-4774-4f47-81e2-c7b2b4cb051d">
<td align="left" stylecode="Lrule Botrule Rrule" valign="top">Doxazosin mesylate 4 mg</td>
<td align="left" stylecode="Rrule" valign="top"> 46</td>
<td align="left" stylecode="Rrule" valign="top"> 16.6</td>
<td align="left" stylecode="Rrule" valign="top"> -6.1<footnoteref idref="id-6b3d9dd2-9d9b-4181-a141-14ba88002bb7"></footnoteref>
</td>
<td align="left" stylecode="Rrule" valign="top"> 46</td>
<td align="left" stylecode="Rrule" valign="top"> 9.6</td>
<td align="left" stylecode="Botrule Rrule" valign="top"> +2.6</td>
</tr>
</tbody>
</table>